The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity
Y Xiong, BB Mi, Z Lin, YQ Hu, L Yu, KK Zha… - Military Medical …, 2022 - Springer
Bone, cartilage, and soft tissue regeneration is a complex spatiotemporal process recruiting
a variety of cell types, whose activity and interplay must be precisely mediated for effective …
a variety of cell types, whose activity and interplay must be precisely mediated for effective …
Mesenchymal stem cell-derived exosomes: applications in regenerative medicine
Exosomes are a type of extracellular vesicles, produced within multivesicular bodies, that
are then released into the extracellular space through a merging of the multivesicular body …
are then released into the extracellular space through a merging of the multivesicular body …
Immune modulation by mesenchymal stem cells
W Jiang, J Xu - Cell proliferation, 2020 - Wiley Online Library
Mesenchymal stem cells (MSCs) can be derived from various adult tissues with multipotent
and self‐renewal abilities. The characteristics of presenting no major ethical concerns …
and self‐renewal abilities. The characteristics of presenting no major ethical concerns …
Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells
R Blazquez, FM Sanchez-Margallo… - Frontiers in …, 2014 - frontiersin.org
In the recent years, it has been demonstrated that the biological activity of mesenchymal
stem cells (MSCs) is mediated through the release of paracrine factors. Many of these …
stem cells (MSCs) is mediated through the release of paracrine factors. Many of these …
Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical …
F De la Portilla, F Alba, D García-Olmo… - International journal of …, 2013 - Springer
Purpose The management of perianal fistula in patients with Crohn's disease is an
extremely challenging medical problem as many fistulas do not respond to available …
extremely challenging medical problem as many fistulas do not respond to available …
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
CJ Rogers, RJ Harman, BA Bunnell… - Journal of translational …, 2020 - Springer
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …
Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome
ME Fernández-Santos, M Garcia-Arranz… - Frontiers in …, 2022 - frontiersin.org
MSCs products as well as their derived extracellular vesicles, are currently being explored
as advanced biologics in cell-based therapies with high expectations for their clinical use in …
as advanced biologics in cell-based therapies with high expectations for their clinical use in …
Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T …
A Ribeiro, P Laranjeira, S Mendes, I Velada… - Stem cell research & …, 2013 - Springer
Introduction The ability to self-renew, be easily expanded in vitro and differentiate into
different mesenchymal tissues, render mesenchymal stem cells (MSCs) an attractive …
different mesenchymal tissues, render mesenchymal stem cells (MSCs) an attractive …
Adipose‐derived stem cells in tissue regeneration: a review
P Zuk - International Scholarly Research Notices, 2013 - Wiley Online Library
In 2001, researchers at the University of California, Los Angeles, described the isolation of a
new population of adult stem cells from liposuctioned adipose tissue. These stem cells, now …
new population of adult stem cells from liposuctioned adipose tissue. These stem cells, now …
Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties …
C Menard, L Pacelli, G Bassi, J Dulong… - Stem cells and …, 2013 - liebertpub.com
Clinical-grade mesenchymal stromal cells (MSCs) are usually expanded from bone marrow
(BMMSCs) or adipose tissue (ADSCs) using processes mainly differing in the use of fetal …
(BMMSCs) or adipose tissue (ADSCs) using processes mainly differing in the use of fetal …